Recruiting NA Nephrolithiasis

Compares treatment options for Nephrolithiasis

Official title HoYAG vs TFL in miniPCNL With ClearPetra

ClinicalTrials.gov ID: NCT07087977

What this study is testing

What it's testing
Mini percutaneous nephrolithotripsy is the treatment of choice for kidney stones over 2cm. This procedure commonly uses laser energy for breaking the stones, and among possible laser platforms, Hoyag and thulium fiber laser are FDA approved.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Males or females over 18 years of age
  • Patients with kidney stones, with stone burden larger than 15 mm.
  • Patients undergoing new percutaneous access with primary, supine, unilateral mini-PCNL.

You likely can't join if

  • Simultaneous use of more than 1 laser platform or other form of fragmentation (e.g., ultrasonic).
  • Patients undergoing simultaneous treatment of contralateral kidney stones during the same procedure.
  • Patients undergoing simultaneous treatment of ureteral stones during the same procedure.
  • Pregnant patients.
  • Presence of genitourinary anatomical abnormalities.
  • Uncorrected coagulopathy.
See the full eligibility criteria
Who can join
  • Males or females over 18 years of age
  • Patients with kidney stones, with stone burden larger than 15 mm.
  • Patients undergoing new percutaneous access with primary, supine, unilateral mini-PCNL.
What rules you out
  • Simultaneous use of more than 1 laser platform or other form of fragmentation (e.g., ultrasonic).
  • Patients undergoing simultaneous treatment of contralateral kidney stones during the same procedure.
  • Patients undergoing simultaneous treatment of ureteral stones during the same procedure.
  • Pregnant patients.
  • Presence of genitourinary anatomical abnormalities.
  • Uncorrected coagulopathy.
  • External urinary catheters.
  • Immunosuppressed patients.
  • Non-elective procedures.

The study team makes the final eligibility decision.

Where it's taking place

  • Kansas City, Kansas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Kansas City, Kansas, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.